Physician profile
Robert C Grumet
NPI 1508055393
$7,277.05
in general payments reported to CMS, 2019-2025
17 companies · $446 in 2025
The $446 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,068 · 2020: $484 · 2021: $725 · 2022: $2,840 · 2023: $427 · 2024: $288 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $2,371.28 | 2019-2022 | |
| Saxum Surgical, INC. | $1,677.36 | 2022-2025 | |
| Smith+Nephew, INC. | $995.39 | 2019 | |
| Pacira Therapeutics, INC. | $699.20 | 2019-2021 | |
| Stryker Corporation | $385.89 | 2021-2024 | Alphavent, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $177.14 | 2025 | Juggerknotless Soft Anchor |
| Vericel Corporation | $168.77 | 2024-2025 | Maci |
| Miach Orthopaedics, INC. | $148.98 | 2025 | |
| Esaote North America, INC. | $144.99 | 2021 | |
| Bioventus LLC | $138.94 | 2020-2025 | Durolane, Xcell |
| Depuy Synthes Sales INC. | $135.60 | 2021-2025 | Monovisc |
| Ge Healthcare | $104.50 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $45.61 | 2024 | Iovera, Zilretta, Exparel |
| Horizon Therapeutics Plc | $27.33 | 2021-2022 | |
| Myoscience INC. | $19.82 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $19.65 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grumet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.